Studies such as those by Bruno et al. (2004) [124] and Johnston et al. (2019) [117] initiated insulin infusions within the first 12 h after stroke onset, aiming to begin before significant ischemic damage developed and to target early harmful cellular mechanisms. The gene discussed is INS; the disease is Stroke.